Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesReproductive Health & FertilityBlue Cross Blue Shield RI Infertility Coverage Upd…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

    Infertility Services (ART, IUI/ICI, IVF, donor gametes, preservation)

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts

    Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs coverage and medical necessity criteria for infertility treatments including artificial insemination (IUI/ICI), in vitro fertilization (IVF) and related services for members of Blue Cross Blue Shield - Rhode Island under the Standard Infertility Services Benefit; notes differences for self-funded expanded plans.

    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicyInfertility Services (ART, IUI/ICI, IVF, donor gametes, preservation)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateApr 1, 2026
    Next Review DateMar 12, 2025
    Key ActionObtain prior authorization for IVF cycles and listed associated procedure codes when eligibility and medical necessity criteria are met.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    1 yr / 6 moInfertility definition timing
    3 AI cyclesAI step requirement
    <10M / <3M / ≤2%Male-factor semen thresholds
    <5%MESA/TESE cutoff
    4+ cyclesIVF cycle review trigger
    12 moMax storage period

    Coverage and Medical Necessity Criteria

    Eligibility Criteria — Members Assigned Female at Birth (AFAB)

    Covered when ALL of the following groups (1, 2 and 3) are satisfied:

    AFAB eligibility

    • Duration or AI cycles or specific diagnoses: One of: (a) documented inability to conceive after 1 year of unprotected intercourse with exposure to sperm (or 6 months if age ≥35); OR (b) inability to conceive after 3 consecutive artificial insemination (AI) cycles (ICI or IUI) performed by a qualified specialist; OR (c) documented infertility due to tubal factor, pelvic adhesive disease, or endometriosis.

      For members who miscarried, prior time attempting to conceive counts toward the required duration.

    • Health status: Member attempting to conceive must be presumably healthy without a history of prior sterilization (or reversal).
    • Menopause exclusion:
    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicyInfertility Services (ART, IUI/ICI, IVF, donor gametes, preservation)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateApr 1, 2026
    Next Review DateMar 12, 2025
    Key ActionObtain prior authorization for IVF cycles and listed associated procedure codes when eligibility and medical necessity criteria are met.
    SourceLink
    On This Page
    Coverage and Medical Necessity CriteriaCPT / HCPCS Code GroupsPrior Authorization, Documentation, and Billing GuidanceTerms and DefinitionsBackground and Policy ScopePolicy Revision History
    Postmenopausal state must not be the cause of infertility, unless the member is under age 43 with premature ovarian failure.

    Eligibility Criteria — Members Assigned Male at Birth (AMAB)

    Coverage for male-factor treatments is available when documented parameters and stated indications are met:

    IVF/ICSI eligibility: Two semen analyses documenting one of: (a) <10 million total motile sperm per ejaculate (pre-wash); OR (b) <3 million total motile sperm (post-wash); OR (c) ≤2% normal forms by Strict Kruger morphology.two semen analyses
    MESA eligibility: MESA is indicated for congenital absence or obstruction of the vas deferens (typically diagnosed by absence of seminal fructose) confirmed on exam. MESA is NOT covered when the chance of live birth is <5%.
    TESE eligibility: TESE is indicated for non-obstructive azoospermia or spinal cord injury causing inability to ejaculate. TESE is NOT covered when the chance of live birth is <5%.

    Medical necessity criteria by service

    Covered when ALL of the following are met for the listed service types:

    Artificial Insemination (ICI/IUI): Artificial insemination cycles (ICI, IUI) are medically necessary when the member AFAB has met the Eligibility Criteria for infertility (AFAB).
    Single Embryo Transfer (SET): Single embryo transfer (SET) IVF is medically necessary when the member AFAB has met Eligibility Criteria for infertility.

    If requested after 4 cycles, additional documentation per 'After 4 In Vitro Fertilization (IVF) Cycles' is required.

    Reciprocal IVF (FET with donor eggs/embryos): Reciprocal IVF using FET with donor eggs or embryos is medically necessary when Eligibility Criteria for AFAB are met AND the member meets ONE of: premature inadequate harvest (≥2 IVF cycles with ≤6 eggs retrieved despite maximal stimulation); absent ovaries prior to age 40; premature ovarian insufficiency; OR genetic egg defects (balanced reciprocal or Robertsonian translocation).

    If requested after 4 cycles, see 'After 4 In Vitro Fertilization (IVF) Cycles'.

    Multiple Embryo Transfer (MET): MET IVF is medically necessary when Eligibility Criteria for AFAB are met AND one or more of: member <35 with diminished ovarian reserve or unsuccessful SET; any age with 2 unsuccessful SET cycles using donor eggs; age 35–37 meeting prior cycle failure conditions; members ≥38 undergoing IVF.

    If requested after 4 cycles, see 'After 4 In Vitro Fertilization (IVF) Cycles'.

    Sperm retrieval procedures (MESA/TESE/TESA): Sperm retrieval procedures are covered when indicated: MESA for congenital absence/obstruction of vas deferens (absent fructose) confirmed by exam; TESE for non-obstructive azoospermia or spinal cord injury causing inability to ejaculate; TESA for obstructive causes or ejaculatory duct abnormality related to spinal cord injury. MESA and TESE are not covered when chance of live birth is <5%.

    After 4 In Vitro Fertilization (IVF) Cycles

    After four completed IVF cycles without pregnancy and delivery, ALL of the following must be provided for further transfer procedures to be considered:

    Post-4-cycle approval requirements: 1) Documentation of the number and type of all past IVF and AI attempts; 2) Detailed description of a revised IVF methodology with a predicted success rate supported by literature; 3) Documentation that the patient has been informed of the predicted success rate and accepts the proposed services.

    All three items must be supplied for review and approval of additional transfer procedures.

    Selected medical necessity and evidence stances

    Selected policy-level coverage and evidence stances:

    Donor sperm coverage: Donor sperm is covered when used as part of infertility treatment for AFAB members who meet Eligibility Criteria, including when no AMAB partner exists or partner infertility is present; procurement services are covered but fees for finding a donor are not covered.

    From policy text regarding donor sperm and procurement.

    Blastocyst transfer: Blastocyst (extended culture) transfer may be considered medically necessary based on RCTs and meta-analyses demonstrating higher live birth rates versus cleavage-stage transfer.

    Based on evidence summaries in the policy.

    EmbryoGlue (HA-enriched medium): Available randomized trial data do not demonstrate improved live birth rates with HA-enriched transfer medium (EmbryoGlue) compared with standard medium; evidence is insufficient to establish clinical benefit.
    Assisted hatching: Randomized trials and meta-analyses have not shown a significant improvement in live birth rates with assisted hatching; clinical pregnancy rate may be improved but live birth benefit is not established.
    Embryo co-culture lacks controlled-trial evidence of improved implantation or pregnancy rates and no standardized method has emerged; not established as effective.

    Evidence-based statements and indicated medically necessary procedures

    Evidence-based statements and procedures the policy considers medically necessary in specified indications:

    Embryo co-culture evidence: No controlled trials demonstrate improved implantation or pregnancy rates with embryo co-culture; no standardized method has emerged.

    Co-culture not supported by controlled evidence.

    EmbryoGlue description: EmbryoGlue is a hyaluronic-acid–enriched transfer medium investigated to assist implantation; randomized data did not show improved live birth rates in a trial cited by the policy.

    Evidence insufficient for benefit.

    ICSI clinical role: ICSI is effective for male-factor infertility (severe oligozoospermia, poor motility, abnormal morphology) with high fertilization and reported pregnancy/live birth rates; clinical reviewers consider ICSI and testicular tissue cryopreservation medically necessary in certain azoospermia cases.

    Iatrogenic Infertility — Cryopreservation and Storage

    Cryopreservation, storage and thawing services are medically necessary when ALL of the iatrogenic infertility criteria are met:

    Iatrogenic infertility requirement: Medical necessity criteria for iatrogenic infertility have been met (member is undergoing medical treatment likely to cause infertility, e.g., surgery, radiation, chemotherapy, or other treatment affecting reproductive organs or processes).

    When iatrogenic infertility criteria are not met these codes are not covered.

    Cryopreservation, Storage and Thawing

    Covered when the medical necessity criteria of iatrogenic infertility are met:

    Cryopreservation/Storage/Thawing coverage: Cryopreservation, storage and thawing codes listed in the policy are medically necessary when iatrogenic infertility criteria are met.

    Claims for multiyear storage or storage beyond 12 months are not covered; coverage is limited to one year (12 months) per benefit year.

    Diagnostic Evaluation of Infertility

    Diagnostic evaluation services that are covered (these are considered diagnostic and not part of the infertility benefit):

    Diagnostic procedures: Covered diagnostic procedures include vasotomy/vasal procedures, artificial insemination services (58321-58323), sperm washing/preparation (58323, 89260-89261), and semen analysis variants (89300–89321) used for diagnostic evaluation.

    These services are covered under applicable diagnostic benefits and are not counted as part of the infertility cycle benefit.

    Diagnostic Evaluation of Infertility - Covered Services

    Covered diagnostic services for evaluation of infertility include:

    Semen analysis and related tests: Coverage includes semen analyses (presence/motility, motility and count, complete analysis, strict morphology/Kruger), sperm antibody testing, functional sperm tests (hamster penetration), and complex sperm preparation for insemination or diagnosis.

    Codes include 89300, 89310, 89320, 89321, 89322, 89325, 89329, and 89261.

    Tubal diagnostic/surgical procedures: Chromotubation of the oviduct (58350) and tubotubal anastomosis (58750) are listed among covered diagnostic services.

    Diagnostic Evaluation — covered services

    Covered diagnostic evaluations (as listed):

    Listed diagnostic tests: Semen analyses (various CPT lab codes), sperm antibody and penetration tests, chromotubation (58350), and tubotubal anastomosis (58750) are presented as covered diagnostic services in the Diagnostic Evaluation section.

    The policy enumerates codes but does not attach separate medical-necessity decision logic to these diagnostic codes.

    Diagnostic Evaluation - Covered Codes

    Covered when billed using the listed procedure and laboratory codes:

    Listed codes coverage: Services corresponding to the enumerated CPT/HCPCS laboratory and procedure codes are listed as covered diagnostic evaluation of infertility.

    See coding section for the full code list (examples include 89300–89331, 58350, 58750).

    Diagnostic Evaluation - Covered Codes

    Covered diagnostic infertility evaluation services (listed codes):

    Covered codes list: Semen analyses (89300, 89310, 89320, 89321, 89322, 89325), sperm antibody testing (89329), specialized sperm tests (89330, 89331), chromotubation (58350), and tubotubal anastomosis (58750) are listed as covered services in this section.

    These services are billed under diagnostic benefits and not as part of the infertility treatment case-rate.

    The policy excludes payment for the cost of donor sperm procurement, processing, and storage. While related implantation services provided as part of infertility treatment may be submitted to BCBSRI for reimbursement, charges associated with obtaining donor sperm (the procurement/processing/storage fees) are not covered.

    The policy states that home artificial insemination (AI) — including member-performed intracervical insemination (ICI) or home intrauterine insemination (IUI) — is not a covered service. Covered AI cycles are those performed under the plan benefit (for example, the documented three clinical AI cycles described elsewhere); self-administered home AI cycles are excluded.

    The policy treats normal menopause as a nonmedical condition for eligibility purposes. Members who have undergone normal menopause do not meet the plan's eligibility criteria for infertility services; an elevated FSH and amenorrhea after age 42 are considered normal menopause under this policy, whereas menopause occurring prior to age 42 is not considered normal menopause.

    Charges billed by an egg donation facilitation agency are not covered. The policy specifies that fees associated with locating or contracting with an egg donor — including donor transportation costs that some agencies cover — are not reimbursable. Once a donor is identified, clinical services such as egg retrieval and implantation-related procedures may be submitted for reimbursement, but facilitation/agency fees and donor travel are excluded.

    Fees charged by egg donation facilitation agencies — including costs related to donor identification, donor stipends, and donor transportation — are explicitly not covered. The policy distinguishes these facilitation/agency charges from clinical services (e.g., egg retrieval) that, once performed, may be billed to BCBSRI.

    Infertility services requested for a member who previously underwent voluntary sterilization are generally excluded from coverage. Such requests will undergo clinician review; coverage may only be considered when review documents that the prior sterilization is unrelated to the current inability to conceive. Otherwise the contractual exclusion applies and services will be administratively denied.

    Cryopreservation, storage, and thawing of embryos, sperm, or reproductive tissues are not covered unless the member meets the medical necessity criteria for iatrogenic infertility. The codes for cryopreservation and associated storage/thawing are designated medically necessary only when iatrogenic infertility criteria are satisfied; for all other members these services are excluded.

    The policy identifies reversal of voluntary sterilization as a noncovered service. Additionally, services related to surrogate parenting are excluded when the surrogate is not a plan member; fees associated with donor facilitation or surrogate arrangements (when the surrogate is not covered) are not payable by the plan.

    Home artificial insemination cycles performed by the member (ICI or IUI at home) are explicitly listed as not covered. Clinical AI cycles performed under the benefit (documented and provider-administered ICI/IUI) differ from home AI and are addressed elsewhere in the policy.

    All services related to surrogate parents are excluded from coverage when the surrogate is not a member of this plan. The policy defines surrogacy and clarifies that gestational or traditional surrogate services will not be paid if the surrogate herself is not covered under the member's plan.

    As noted elsewhere, services related to surrogate parenting are not covered when the surrogate is not a plan member. This reiterates the exclusion for surrogate-associated services in cases where the surrogate does not have plan coverage.

    The coding section enumerates procedure and case-rate codes that require prior authorization for IVF cycles; there are no separate, additional exclusions listed in this part of the coding section beyond the listed PA requirements.

    For members who do not meet the medical necessity criteria for iatrogenic infertility, cryopreservation, storage, and thawing codes are not covered. The policy conditions coverage of these services on documented medical necessity that reproductive capacity will be impaired by planned medical treatment.

    The policy limits storage coverage to one benefit year: multiyear storage or storage beyond 12 months is not covered. Even when iatrogenic infertility criteria are met, claims for storage longer than 12 months (multiyear storage) will be denied; coverage is available up to one year (12 months) per benefit year.

    This restates that multiyear storage or any storage period exceeding 12 months is not covered; coverage of storage is limited to a maximum of 12 months per benefit year and multiyear storage claims will be denied.

    The diagnostic evaluation sections (as presented in these chunks) primarily list covered diagnostic procedure and laboratory codes; they do not contain explicit exclusion language in the excerpted diagnostic code listings.

    The diagnostic code listings provided here enumerate covered semen analyses and related tests; within these chunks no explicit exclusions are stated beyond those detailed elsewhere in the policy.

    These diagnostic evaluation excerpts focus on covered semen analysis and related procedures; no explicit exclusionary language is present in this portion of the document.

    This excerpt reiterates covered diagnostic procedure and lab codes for infertility evaluation; the text shown does not include explicit exclusions and largely repeats the covered code list.

    The listed diagnostic code blocks present covered semen analyses, sperm functional tests, and tubal procedures; the content is a repetitive listing of covered codes and does not explicitly provide exclusionary statements within these chunks.

    MESA and TESE are designated as not covered when the chance of live birth is less than 5%. Requests for these sperm-retrieval procedures should document the predicted probability of live birth; if that probability is under 5%, the policy states these services are not payable.

    EmbryoGlue® (hyaluronic-acid–enriched transfer medium, CPT 89398) is considered not medically necessary. The policy concludes that current evidence is insufficient to show improved live birth outcomes with EmbryoGlue and therefore it is not supported as medically necessary.

    The Hyaluronan Binding Assay for sperm evaluation is explicitly not covered for Medicare Advantage plans and is considered not medically necessary for Commercial products due to insufficient evidence of improved health outcomes.

    The policy notes that adjunct laboratory techniques such as EmbryoGlue, assisted hatching, and embryo co-culture lack sufficient evidence of improved live birth rates. Assisted hatching has not demonstrated a consistent live birth benefit in RCTs and meta-analyses, EmbryoGlue trials have not shown an improvement in live birth, and embryo co-culture lacks controlled-trial evidence and a standardized method; collectively these techniques are not supported as established, effective therapies.

    Embryo co-culture is specifically noted as having no controlled trials demonstrating improved implantation or pregnancy rates and no standardized method; as a result the policy does not support co-culture as an effective intervention.

    The document reiterates that cryopreservation, storage, and thawing codes are not covered for members who do not meet the iatrogenic infertility criteria. Coverage for these services is conditional on documented risk of iatrogenic infertility; absent that medical necessity, such claims will be denied.

    CPT / HCPCS Code Groups

    Referenced specific CPT codeCPT
    89398EmbryoGlue®
    Not medically necessary / specific CPTCPTNot Covered
    89398EmbryoGlue® (hyaluronic acid)
    Codes Requiring Prior Authorization — IVF Cyclesmixed
    58970Follicle puncture for oocyte retrieval, any method
    58974Embryo transfer, intrauterine
    58976Gamete, zygote or embryo intrafallopian transfer, any method
    76948Ultrasonic guidance for aspiration of ova, imaging supervision and interpretation
    89250Culture of oocyte(s)/embryo(s), less than 4 days
    89251Culture of oocyte(s)/embryo(s), less than 4 days; with co-culture of oocyte(s)/embryo(s)
    89253Assisted embryo hatching, microtechniques (any method)
    89254Oocyte identification from follicular fluid
    89280Assisted oocyte fertilization, microtechnique; less than or equal to 10 oocytes
    89281Assisted oocyte fertilization, microtechnique; greater than 10 oocytes
    1–10 of 13
    1/2
    Covered CPT Codes requiring prior authorizationCPTCovered
    89253Oocyte identification from follicular fluid
    89254Oocyte identification from follicular fluid
    89280Assisted oocyte fertilization, microtechnique; less than or equal to 10 oocytes
    89281Assisted oocyte fertilization, microtechnique; greater than 10 oocytes
    Case-rate S-codes requiring prior authorizationHCPCSCovered
    S4011In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development
    S4013Complete cycle, gamete intrafallopian transfer (GIFT), case rate
    S4014Complete cycle, zygote intrafallopian transfer (ZIFT), case rate
    S4015Complete in vitro fertilization cycle, not otherwise specified, case rate
    S4016Frozen in vitro fertilization cycle, case rate
    S4017Incomplete cycle, treatment cancelled prior to stimulation, case rate
    Codes Requiring Prior Authorizationmixed
    S4011In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development
    S4013Complete in vitro fertilization cycle, not otherwise specified, case rate
    S4014Complete cycle, gamete intrafallopian transfer (GIFT), case rate
    S4015Complete cycle, zygote intrafallopian transfer (ZIFT), case rate
    S4016Frozen in vitro fertilization cycle, case rate
    S4017Incomplete cycle, treatment cancelled prior to stimulation, case rate
    S4018Frozen embryo transfer procedure cancelled before transfer, case rate (NSR)
    S4020In vitro fertilization procedure cancelled before aspiration, case rate
    89280Assisted oocyte fertilization, microtechnique; greater than 10 oocytes
    89281Assisted oocyte fertilization, microtechnique
    Codes Requiring Prior Authorization — IVF cycles (HCPCS S-codes)HCPCSCovered
    S4013Complete cycle, gamete intrafallopian transfer (GIFT), case rate
    S4014Complete cycle, zygote intrafallopian transfer (ZIFT), case rate
    S4015Complete in vitro fertilization cycle, not otherwise specified, case rate
    S4016Frozen in vitro fertilization cycle, case rate
    S4017Incomplete cycle, treatment cancelled prior to stimulation, case rate
    S4018Frozen embryo transfer procedure cancelled before transfer, case rate (NSR)
    S4020In vitro fertilization procedure cancelled before aspiration, case rate
    S4021In vitro fertilization procedure cancelled after aspiration, case rate
    Codes Requiring Prior Authorization — IVF Cycles (S-codes)mixed
    S4013Complete cycle, gamete intrafallopian transfer (GIFT), case rate
    S4014Complete cycle, zygote intrafallopian transfer (ZIFT), case rate
    S4015Complete in vitro fertilization cycle, not otherwise specified, case rate
    S4016Frozen in vitro fertilization cycle, case rate
    S4017Incomplete cycle, treatment cancelled prior to stimulation, case rate
    S4018Frozen embryo transfer procedure cancelled before transfer, case rate
    S4020In vitro fertilization procedure cancelled before aspiration, case rate
    S4021In vitro fertilization procedure cancelled after aspiration, case rate
    S4022Assisted oocyte fertilization, case rate
    S4023Assisted oocyte fertilization, case rate (additional)
    Cryopreservation, Storage and Thawing CodesCPTCovered
    89258Cryopreservation; embryo(s)
    89259Cryopreservation; sperm
    89335Cryopreservation, reproductive tissue, testicular
    89337Cryopreservation, mature oocyte(s)
    89342Storage (per year); embryo(s)
    89343Storage (per year); sperm/semen
    89344Storage (per year); reproductive tissue, testicular/ovarian
    89346Storage (per year); oocyte
    89354Thawing of cryopreserved; reproductive tissue; testicular/ovarian
    89356Thawing of cryopreserved; oocytes, each aliquot
    1–10 of 11
    1/2
    Cryopreservation, storage and thawing (medically necessary when iatrogenic infertility criteria met)CPT|HCPCSCovered
    89258Cryopreservation; embryo(s)
    89259Cryopreservation; sperm
    89335Cryopreservation, reproductive tissue, testicular
    89337Cryopreservation, mature oocyte(s)
    89342Storage (per year); embryo(s)
    89343Storage (per year); sperm/semen
    89344Storage (per year); reproductive tissue, testicular/ovarian
    89346Storage (per year); oocyte
    89354Thawing of cryopreserved; reproductive tissue; testicular/ovarian
    89356Thawing of cryopreserved; oocytes, each aliquot
    1–10 of 11
    1/2
    Diagnostic evaluation of infertility — procedures and semen analysisCPTCovered
    55200Vasotomy, cannulization with or without incision of Vas, unilateral or bilateral (separate procedure)
    58321Artificial insemination; intra-cervical
    58322Artificial insemination; intra-uterine
    58323Sperm washing for artificial insemination
    58350Chromotubation of oviduct, including materials
    58750Tubotubal anastomosis
    89260Sperm isolation; simple prep (e.g., sperm wash and swim-up) for insemination or diagnosis with semen analysis
    89261Sperm isolation; complex prep (e.g., Percoll gradient, albumin gradient) for insemination or diagnosis with semen analysis
    89300Semen analysis; presence and/or motility of sperm including Huhner test (post coital) (lab)
    89310Semen analysis; motility and count (not including Huhner test) (lab)
    1–10 of 12
    1/2
    Covered procedure and lab codes (Diagnostic evaluation)CPTCovered
    89300Semen analysis; presence and/or motility of sperm including Huhner test (post coital) (lab)
    89310Semen analysis; motility and count (not including Huhner test) (lab)
    89320Semen analysis; complete (volume, count, motility and differential) (lab)
    89321Semen analysis, presence and/or motility of sperm
    89322Semen analysis: volume, count, and differential using strict morphologic criteria (e.g.,Kruger) (lab)
    89325Sperm antibodies (lab)
    89261Sperm isolation; complex prep (e.g., Percoll gradient, albumin gradient) for insemination or diagnosis with semen analysis
    58350Chromotubation of oviduct, including materials
    58750Tubotubal anastomosis
    Covered CPT/Lab CodesCPTCovered
    89300Semen analysis; presence and/or motility of sperm including Huhner test (post coital) (lab)
    89310Semen analysis; motility and count (not including Huhner test) (lab)
    89320Semen analysis; complete (volume, count, motility and differential) (lab)
    89321Semen analysis, presence and/or motility of sperm
    89322Semen analysis: volume, count, and differential using strict morphologic criteria (e.g.,Kruger) (lab)
    89325Sperm antibodies (lab)
    89329Sperm evaluation; hamster penetration test (lab)
    89261Sperm isolation; complex prep (e.g., Percoll gradient, albumin gradient) for insemination or diagnosis with semen analysis
    58350Chromotubation of oviduct, including materials
    58750Tubotubal anastomosis
    Covered diagnostic CPT/lab and related procedure codesCPTCovered
    89300Semen analysis; presence and/or motility of sperm including Huhner test (post coital) (lab)
    89310Semen analysis; motility and count (not including Huhner test) (lab)
    89320Semen analysis; complete (volume, count, motility and differential) (lab)
    89321Semen analysis, presence and/or motility of sperm
    89322Semen analysis: volume, count, and differential using strict morphologic criteria (e.g.,Kruger) (lab)
    89325Sperm antibodies (lab)
    89329Sperm evaluation; hamster penetration test (lab)
    89330Sperm evaluation; cervical mucus penetration test, with or without spinnbarkeit test (lab)
    58350Chromotubation of oviduct, including materials
    58750Tubotubal anastomosis
    Covered procedure and lab codesCPT | HCPCS | mixedCovered
    89300Semen analysis; presence and/or motility of sperm including Huhner test (post coital) (lab)
    89310Semen analysis; motility and count (not including Huhner test) (lab)
    89320Semen analysis; complete (volume, count, motility and differential) (lab)
    89321Semen analysis, presence and/or motility of sperm
    89322Semen analysis: volume, count, and differential using strict morphologic criteria (e.g.,Kruger) (lab)
    89325Sperm antibodies (lab)
    89329Sperm evaluation; hamster penetration test (lab)
    89330Sperm evaluation; cervical mucus penetration test, with or without spinnbarkeit test (lab)
    89331Code listed in document (no description provided in excerpt)
    58350Chromotubation of oviduct, including materials
    1–10 of 11
    1/2
    Covered procedure/lab CPT codes (diagnostic infertility evaluation)CPTCovered
    89300Semen analysis; presence and/or motility of sperm (including Huhner test) (lab)
    89310Semen analysis; presence and/or motility of sperm including Huhner test (post coital) (lab)
    89320Semen analysis; motility and count (not including Huhner test) (lab)
    89321Semen analysis; complete (volume, count, motility and differential) (lab)
    89322Semen analysis; presence and/or motility of sperm
    89325Semen analysis: volume, count, and differential using strict morphologic criteria (e.g.,Kruger) (lab)
    89329Sperm antibodies (lab)
    89330Sperm evaluation; hamster penetration test (lab)
    89331Sperm evaluation; cervical mucus penetration test, with or without spinnbarkeit test (lab); also listed for urine sperm evaluation for retrograde ejaculation
    58350Chromotubation of oviduct, including materials
    1–10 of 11
    1/2
    Infertility definition and semen-analysis thresholds
    Infertility (AFAB)Documented inability to conceive after 1 year of unprotected intercourse with exposure to sperm (6 months if age ≥35).
    Semen thresholds (AMAB) — pre-wash< 10 million total motile sperm per ejaculate on two separate semen analyses.
    Semen thresholds (AMAB) — post-wash< 3 million total motile sperm (post-wash) on two separate semen analyses.
    Semen morphology threshold≤ 2% normal forms by Strict Kruger morphology on two separate semen analyses.

    Prior Authorization, Documentation, and Billing Guidance

    Prior Authorization

    Prior authorization may be required

    Some infertility services require prior authorization after eligibility is confirmed because Medical Necessity Criteria must also be satisfied; check PA rules before scheduling services.

    • Prior authorization may be required even when eligibility criteria are met.
    Prior Authorization

    Prior authorization required for IVF and related services

    Prior authorization is required for IVF cycles (complete, partial, incomplete), components of IVF (retrieval, fertilization, ICSI, transfers, MESA/TESE/TESA), donor egg cycles, frozen cycles, and services related to iatrogenic infertility (cryopreservation, storage, monitoring, thawing). PA is required for Medicare Advantage and recommended for Commercial products.

    • IVF cycles (complete/partial/incomplete) and components (oocyte retrieval, assisted fertilization, embryo incubation/transfer, SET/MET, donor services, ICSI, MESA/TESE/TESA)
    • Services related to iatrogenic infertility (cryopreservation, storage, monitoring, thawing)
    Denial Risk

    Clinical review and claim submission for sterilization-related cases

    Requests for infertility services where prior sterilization may be relevant will be reviewed by a clinician; a determination that the contractual sterilization exclusion applies is an administrative denial (not a medical necessity determination).

    • Clinician review required for members with prior sterilization; administrative denial possible if exclusion applies.
    • Submit implantation-related services for reimbursement to BCBSRI as directed.
    Documentation Required

    IVF cycle definition for authorization and counting

    For the policy’s cycle limit, each embryo transfer procedure (single or multiple embryo) counts as one IVF cycle; providers should use this definition when requesting authorizations and tracking cycle counts.

    • 1 embryo transfer procedure (fresh or frozen) = 1 IVF cycle for cycle-limit purposes.
    Prior Authorization

    Prior authorization required for IVF cycles (CPTs and S‑codes)

    Prior authorization is required for IVF cycles and related microtechnique CPTs and HCPCS case‑rate S‑codes; providers must obtain PA for the listed CPTs (e.g., 89253, 89254, 89280, 89281) and S‑codes (S4011–S4018, S4020–S4021) before services are rendered to avoid denials.

    • CPTs: 89253, 89254, 89280, 89281 (assisted fertilization/identification procedures)
    • HCPCS S‑codes: S4011, S4013–S4018, S4020–S4021 (complete/frozen/incomplete/cancelled cycle case rates)
    Prior Authorization

    Prior authorization required for IVF case‑rate S‑codes

    Providers must obtain prior authorization for IVF case‑rate S‑codes (e.g., S4011, S4013–S4018, S4020, S4021); failure to obtain PA for these S‑codes may result in claim denial.

    • S‑codes listed as requiring PA include S4011, S4013–S4018, S4020, S4021 (complete, frozen, incomplete, and cancelled cycle case rates).
    Prior Authorization

    IVF cycles S‑codes require prior authorization before services

    PA is required for the IVF cycle S‑codes and related case‑rate codes; obtain authorization before services are rendered to avoid denial of claims billed with these S‑codes.

    • Ensure PA is in place for S4013–S4018, S4020–S4021 and related S‑codes prior to billing.
    Documentation Required

    Cryopreservation/storage/thawing require iatrogenic‑infertility medical necessity

    Cryopreservation, storage, and thawing codes are medically necessary only when the iatrogenic infertility criteria are met; even then, storage coverage is limited to one year (12 months) per benefit year and multiyear storage or storage over 12 months will be denied.

    • Cryopreservation/storage/thawing codes (e.g., 89258, 89259, 89335, 89337, 89342, 89343, 89344, 89346, 89354, 89356, S4027) require iatrogenic infertility criteria to be met.
    • Claims for storage beyond 12 months per benefit year are not covered and will be denied.
    Note

    Diagnostic evaluation codes listed as covered (no separate PA stated)

    The policy lists covered diagnostic infertility procedure and lab codes (e.g., 89300–89322, 89261, 58350, 58750); these diagnostic codes are presented as covered but the document does not state a separate prior authorization requirement for diagnostic evaluation codes in these sections.

    • Covered diagnostic codes include semen analyses (89300, 89310, 89320–89322), sperm prep (89260–89261), chromotubation (58350), and tubotubal anastomosis (58750).
    • No explicit PA rule for diagnostic codes stated in chunks cited.
    Prior Authorization

    Possible prior authorization for listed procedures (58350, 58750)

    Chromotubation (CPT 58350) and tubotubal anastomosis (CPT 58750) are listed among covered diagnostic/surgical procedures; prior authorization may be required for surgical procedures per payer policy, so verify PA requirements before performing these procedures.

    • Chromotubation 58350 and tubotubal anastomosis 58750 appear in covered services lists; check payer for PA for surgical procedures.
    Note

    Prior authorization — listed diagnostic codes (diagnostics covered; no PA stated)

    The Diagnostic Evaluation sections enumerate CPT/lab codes that are covered for infertility workup (multiple semen analysis and related tests); the chunks do not state a separate prior authorization requirement for these diagnostic codes.

    • Providers should bill diagnostic evaluation services using the listed CPT/lab codes (e.g., 89300–89322, 89325, 89329–89331, 58350, 58750).
    • No explicit PA trigger for these diagnostic codes is provided in the cited sections.
    Documentation Required

    Procedure codes listed (no PA stated) — document and verify PA if needed

    The diagnostic procedure code listings for infertility evaluation enumerate covered CPT/lab codes but do not state explicit prior authorization requirements in these chunks; providers should document and bill using the listed codes and confirm PA rules with BCBSRI when in doubt.

    • Document the specific CPT/lab tests performed (e.g., semen analyses 89300–89322) when submitting claims.
    • If unsure about PA for a diagnostic procedure, verify with BCBSRI prior to performing the service.
    Step Therapy

    Three consecutive AI cycles may be required as an eligibility step

    Coverage may require three consecutive AI cycles (ICI or IUI) performed by a qualified specialist as an alternative pathway to meet eligibility prior to other services; document the AI cycle history when requesting further services.

    • Three consecutive AI (ICI or IUI) cycles performed by a qualified specialist can satisfy eligibility as an alternative to duration criteria.
    • Costs for the three AI cycles (medications, professional, facility) are covered; home AI is not covered.
    Note

    AI/IUI medically necessary when AFAB eligibility criteria met

    Artificial insemination (ICI/IUI) is medically necessary when the AFAB member meets the Eligibility Criteria for infertility; document that eligibility criteria were met when authorizing or billing AI services.

    • ICI and IUI are medically necessary treatments when AFAB eligibility criteria are satisfied.
    • Document eligibility (duration or prior AI attempts or specified diagnoses) in the medical record.
    Documentation Required

    Document infertility per duration or semen analysis thresholds

    Documented infertility must be supported by duration criteria for AFAB members (1 year unprotected intercourse or 6 months if ≥35) or by two semen analyses for AMAB members showing the specified thresholds; providers should include these findings in requests for coverage.

    • AFAB: document inability to conceive after 1 year (or 6 months if age ≥35).
    • AMAB: two semen analyses documenting <10M total motile sperm (pre‑wash) or <3M (post‑wash) or ≤2% normal forms (Strict Kruger).
    Documentation Required

    Documentation required for requests after >4 IVF cycles

    After four IVF cycles that do not result in pregnancy and delivery, the requesting physician must provide documentation of (1) number and type of prior IVF/AI attempts, (2) a revised IVF methodology with predicted success rate supported by literature, and (3) documentation that the patient has been informed of and accepts the predicted success rate; all three items (Must Have ALL) must be submitted for further transfer approval.

    • Provide detailed past IVF/AI attempt history (number/type).
    • Provide revised treatment plan and literature‑supported predicted success rate.
    • Provide documented patient counseling and written acceptance of predicted success rate.
    Billing Rule

    Documentation and billing for donor gametes; agency/transport fees not covered

    When donor eggs or sperm are used, implantation and procurement services are covered and should be submitted to BCBSRI for reimbursement; however, fees charged by egg‑donation facilitation agencies and donor transportation are not covered and may be denied.

    • Implantation and procurement services billed by the treating facility/provider should be submitted to BCBSRI.
    • Charges from egg donation facilitation agencies and donor transportation fees are not covered.
    Billing Rule

    Member‑submitted donor reimbursement requires BCBSRI form

    If a member was billed directly for donor egg or sperm, the member must use the BCBSRI Donor Egg and Sperm Reimbursement Form when submitting a claim for reimbursement.

    • Use the BCBSRI Donor Egg & Sperm Reimbursement Form for member‑submitted donor reimbursement claims (form linked in policy).
    Documentation Required

    Document IVF services (visits, drugs, labs, procedures) as part of the cycle

    Services included within an IVF procedure (office visits, medications, labs/pathology, surgical procedures) occur as part of the IVF cycle and should be documented as such when submitting prior authorization requests and claims.

    • Document that office visits, drugs, labs, pathology, and surgical procedures were provided as part of an IVF cycle when requesting PA or submitting claims.
    • Include associated microtechnique CPTs when seeking authorization for IVF cycle case rates.
    Documentation Required

    Procedure coordination and documentation for TESA/TESE

    TESA and TESE procedural coordination (timing with egg retrieval, anesthesia settings, and cryopreservation) should be documented and coordinated with the IVF/ICSI plan when these sperm retrieval procedures are performed.

    • Document coordination of TESA/TESE with egg retrieval and any cryopreservation performed.
    • Include procedural details (anesthesia, local vs sedation) in the record for authorization/claims.
    Prior Authorization

    Submit PA for complete/frozen/incomplete IVF case‑rate codes and microtechnique CPTs

    Providers must submit prior authorization for complete, frozen, and incomplete IVF cycle case rates and associated microtechnique CPTs as listed in the policy; PA is required for these case‑rate and microtechnique codes.

    • Submit PA for case‑rate codes S4011, S4013–S4018, S4020–S4021 and associated CPT microtechnique codes (e.g., 89280, 89281).
    • PA must be obtained before services to avoid claim denials.
    Prior Authorization

    PA required for listed HCPCS S‑codes and CPT 89280/89281

    Prior authorization is required for the IVF cycle case‑rate HCPCS S‑codes (S4011–S4021 series) and CPT codes 89280 and 89281; providers must include these codes on PA requests and ensure authorization is in place before performing services.

    • List HCPCS S4011–S4021 and CPTs 89280, 89281 on PA request forms.
    • Confirm PA approval prior to scheduling IVF cycle components or case‑rate services.
    Billing Rule

    Use S‑codes in claims and PA requests for infertility/IVF services

    BCBSRI participating facilities primarily use S‑codes when reporting infertility/IVF services; providers should document and bill with the appropriate S‑code(s) listed in the policy when submitting claims and prior authorization requests.

    • Use S‑codes (e.g., S4013–S4021) for reporting infertility/IVF services where applicable.
    • Ensure PA and documentation reference the same S‑codes used on claims.
    Documentation Required

    Iatrogenic‑infertility requirement for cryopreservation/storage/thawing coverage

    Cryopreservation, storage and thawing codes are covered only when the member meets the iatrogenic infertility medical necessity criteria; otherwise these codes are not covered and claims will be denied.

    • Iatrogenic infertility criteria must be met for codes (89258, 89259, 89335, 89337, 89342–89346, 89354, 89356, S4027) to be considered medically necessary.
    • For members not meeting iatrogenic criteria, cryopreservation/storage/thawing codes are not covered.
    Documentation Required

    Document specific semen analysis/sperm tests by CPT when submitting claims

    The policy provides a list of covered diagnostic procedure and semen analysis CPT/lab codes; providers should document which specific semen analysis or sperm test was performed using the listed CPT/lab code when submitting claims or clinical documentation.

    • Document the exact semen analysis performed (e.g., 89300, 89310, 89320, 89321, 89322, 89325, 89329) and reference the CPT code on claims.
    • Include related procedures (e.g., chromotubation 58350, tubotubal anastomosis 58750) when applicable.
    Denial Risk

    MESA/TESE excluded when chance of live birth is <5%

    MESA and TESE are not covered when there is less than a 5% chance of live birth; providers should not submit claims for MESA/TESE when predicted live‑birth probability is <5% as these will be denied.

    • MESA and TESE coverage excluded if <5% chance of live birth.
    • Assess and document predicted live‑birth probability before requesting PA or submitting claims for MESA/TESE.
    Denial Risk

    Sterilization‑related review and administrative denial risk

    Requests for infertility services for members with a prior sterilization procedure will be reviewed by a clinician; if the contractual exclusion applies, the request will be administratively denied—ensure documentation demonstrates sterilization is unrelated to current infertility if seeking coverage.

    • Clinician review required for prior sterilization cases.
    • Provide documentation demonstrating prior sterilization is unrelated to current inability to conceive if applicable.
    Billing Rule

    Egg donation facilitation agency charges not covered — bill clinical services to BCBSRI

    Charges from egg donation facilitation agencies (including fees for finding a donor and donor transportation) are not covered and may be denied; once a donor is identified, services related to egg retrieval and implantation performed by the participating facility/provider should be submitted to BCBSRI for reimbursement.

    • Egg donation facilitation agency fees and donor transportation costs are not covered.
    • Bill implantation and retrieval services to BCBSRI via the performing facility/provider after donor is identified.
    Denial Risk

    Surrogate‑related services excluded when surrogate is not plan member

    All services related to surrogate parents are excluded from coverage when the surrogate is not a plan member; do not submit claims for surrogate‑related services for non‑member surrogates.

    • Surrogate‑related services are excluded if the surrogate is not a member of this plan.
    • Reciprocal IVF (where member is recipient) is distinct and potentially covered when eligibility criteria are met.
    Denial Risk

    Claims for listed IVF CPT/S‑codes may be denied without PA

    Claims for listed IVF‑related CPT and S‑codes may be denied if prior authorization is not obtained; ensure PA is obtained for the enumerated IVF CPTs and HCPCS S‑codes before services are performed to avoid denials.

    • Failure to obtain PA for IVF CPTs (e.g., 89280, 89281, 89253–89254) or S‑codes (S4011–S4021) can result in claim denial.
    • Include required documentation and codes on PA request.
    Denial Risk

    Storage beyond 12 months per benefit year is not covered

    Providers submitting claims for storage beyond one year (12 months) per benefit year should expect denial; multiyear storage or storage over 12 months is not covered even when iatrogenic infertility criteria are met.

    • Storage coverage is limited to 12 months per benefit year; multiyear storage claims will be denied.
    • Plan for annual storage billing within benefit year limits.
    Denial Risk

    Diagnostic evaluation claims risk denial if billed with non‑covered codes or lacking documentation

    Diagnostic infertility evaluation claims may be denied if billed with non‑covered codes or without supporting medical necessity documentation; ensure correct covered CPT/lab codes and documentation are included on claims.

    • Use covered diagnostic CPT/lab codes (e.g., 89300–89322, 89325, 89329–89331, 89261, 58350, 58750) when billing.
    • Attach medical documentation supporting the medical necessity of the diagnostic tests to avoid denial.
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note

    Terms and Definitions

    Artificial insemination (AI) — IUI and ICI
    Artificial Insemination (AI) — policy scopeAI includes intrauterine insemination (IUI) and intracervical insemination (ICI) as services addressed by this policy.
    IUI (definition)Insertion of sperm into the uterus to bypass the cervix; often timed with ultrasound and may use fertility drugs.
    ICI (definition)Insertion of sperm into the cervix; rarely used and may be combined with fertility drugs.
    Home AIMember-performed home AI (ICI or IUI) is described but is listed as non-covered (home/artificial insemination by member at home).
    Reciprocal IVF
    Reciprocal IVF — definitionReciprocal IVF (listed among services addressed) refers to use of donor eggs/embryos with frozen embryo transfer where an AFAB member receives embryos created with a partner's or donor's eggs; defined as a covered form of IVF for AFAB members when Eligibility Criteria are met.
    ContextDistinguished from surrogacy; services related to surrogate parents who are not plan members are excluded from coverage.
    Related servicesReciprocal IVF may involve cryopreserved donor eggs/embryos and implantation services as described in the IVF/covered services sections.
    IVF cycles — definition used in policy
    IVF cycle — general definitionAn IVF cycle consists of controlled ovarian hyperstimulation, egg retrieval, fertilization/ICSI in the lab, embryo transfer, and monitoring — all occurring within one menstrual cycle.
    Cycle counting for limitsFor the purpose of the cycle limit in this policy, each embryo transfer procedure (whether single or multiple embryo) is considered one cycle.
    Modifications/variantsIncludes modified procedures (GIFT, ZIFT, PROST, TEST, TET) though IVF typically involves fertilization in vitro and embryo transfer to the uterus.
    Iatrogenic infertility
    Iatrogenic infertility — definitionImpairment of fertility caused by surgery, radiation, chemotherapy, or other medical treatment (including gender-affirming care) affecting reproductive organs or processes.
    Implication for coverageCryopreservation, storage and thawing services are medically necessary only when iatrogenic infertility criteria are met.
    ExamplesIncludes retrieval and preservation of eggs, embryos, sperm or other tissues when medical treatment may directly or indirectly cause infertility.
    Artificial Insemination (AI) — general definition
    Artificial Insemination (AI) — definitionIntroduction of sperm into a woman's cervix, fallopian tubes, or uterus; AI includes IUI and ICI and is addressed as an assisted reproductive technology in this policy.
    Common methodsIUI (intrauterine) and ICI (intracervical) are the principal AI methods described in the policy.
    Role in care pathwayAI cycles may be required (three consecutive AI cycles) as an alternative pathway prior to authorization of other services for AFAB members per eligibility rules.
    Artificial Intracervical Insemination (ICI)
    Artificial Intracervical Insemination (ICI)Insertion of sperm into the cervix; rarely used because the lower reproductive tract can slow or stop sperm movement; fertility drugs may be used.
    Home ICIMember-performed intracervical insemination at home is described but is non-covered under the policy (home AI not covered).
    Clinical noteICI is one of the AI methods included in the policy's AI definition and coverage considerations.
    Artificial Intrauterine Insemination (IUI)
    Artificial Intrauterine Insemination (IUI)Insertion of sperm into the uterus to bypass the cervix; often timed with ultrasound to maximize chance of pregnancy and may use fertility drugs.
    Home IUIHome-performed IUI is described in the policy but is listed as non-covered (home AI cycles are not covered).
    Use in eligibility/pathwayIUI is a component of AI cycles that may be required as three consecutive cycles for AFAB eligibility alternative pathway prior to other services.
    Assigned Female at Birth (AFAB)
    Assigned Female at Birth (AFAB)Sex assigned to an infant, most often based on anatomical and other biological characteristics; AFAB members have specific eligibility criteria for infertility services.
    Usage in policyAFAB is used to define which services and criteria (e.g., SET, MET, reciprocal IVF) apply to members assigned female at birth.
    Relation to iatrogenic infertilityAFAB members undergoing medical treatments that may cause iatrogenic infertility have separate preservation coverage rules.
    Assigned Male at Birth (AMAB)
    Assigned Male at Birth (AMAB)Sex assigned to an infant, most often based on anatomical and other biological characteristics; AMAB members have male-factor eligibility criteria (semen analysis thresholds) for certain services.
    AMAB clinical servicesAMAB members may be eligible for IVF, ICSI, MESA, TESE, and TESA when documented semen parameters or clinical conditions are met.
    Semen-analysis roleAMAB eligibility relies on documented semen-analysis thresholds (two analyses) per policy definitions.
    Assisted Hatching
    Assisted Hatching — definitionMechanical disruption of the zona pellucida to aid embryo hatching and potentially improve implantation; hypothesized to address zona hardening from in vitro conditions.
    Evidence summaryRandomized controlled trials and meta-analyses have not found a significant improvement in live birth rate with assisted hatching (clinical pregnancy rate may be improved).
    Policy implicationAssisted hatching is discussed but evidence does not establish consistent live-birth benefit per cited trials/meta-analyses.
    Blastocyst Transfer
    Blastocyst Transfer — definitionExtended culture of oocytes/embryos for greater than 4 days to the blastocyst stage; embryos at blastocyst stage have higher implantation probability.
    Evidence summaryRCTs, observational studies and meta-analyses show higher live birth rates with blastocyst transfer compared to cleavage-stage transfer; may be considered medically necessary.
    Clinical rationaleHigher implantation probability permits transferring fewer embryos and reduces multiple pregnancy risk.
    Embryo Co-Culture
    Embryo Co-Culture — definitionUse of feeder cell layers (human or non-human) in embryo culture to attempt to improve embryo development to blastocyst stage.
    Evidence noteNo standardized co-culture method has emerged and no controlled trials demonstrate improved implantation or pregnancy rates; co-culture is not supported by controlled evidence.
    Policy implicationEmbryo co-culture is discussed but lacks controlled-trial evidence to support clinical benefit.
    Infertility — definition and time thresholds
    Infertility — core definitionDocumented inability to conceive after 1 year of unprotected intercourse with exposure to sperm, or 6 months if age ≥35.
    Exclusion — menopauseNormal menopause is a natural condition and is not included as infertility under this definition; premature ovarian failure is a medical cause of infertility.
    Note on prior pregnanciesDuration of attempts to conceive before a prior miscarriage counts toward the 1-year or 6-month period.
    In Vitro Fertilization (IVF)
    In Vitro Fertilization (IVF) — definitionCombining an egg with sperm in a laboratory dish; if fertilization and cell division occur, resulting embryos are transferred to the uterus to attempt implantation.
    Typical procedural stepsIncludes controlled ovarian hyperstimulation, egg retrieval, fertilization (or ICSI), embryo transfer, and post-transfer monitoring.
    Variants and modificationsIncludes related procedures such as GIFT, ZIFT, PROST, TEST, TET; services received as part of IVF may include office visits, drugs, lab/pathology, and surgical procedures.
    Intracytoplasmic Sperm Injection (ICSI)
    ICSI — definitionIntracytoplasmic sperm injection (ICSI) is a microtechnique in which a single sperm is injected directly into an oocyte and is used for severe male-factor infertility.
    Clinical use and outcomesICSI yields high fertilization rates (up to ~76%) and reported pregnancy rates per cycle/transfer (~44.7%–49.6%); considered effective for low sperm count/poor motility.
    Policy stanceICSI and testicular tissue cryopreservation for azoospermia may be considered medically necessary for specific AMAB indications.
    Home Artificial Insemination (AI)
    Home Artificial Insemination (AI)Member-performed insemination at home (ICI or IUI methods) is described in the policy as 'home AI'.
    Coverage exclusionHome AI cycles (member-performed ICI or IUI at home) are explicitly non-covered under this policy.
    Clinical noteWhile described, home AI is not an authorized covered intervention; clinical AI services performed by providers are addressed elsewhere.
    Surrogate — definition and coverage note
    Surrogate — definitionAn individual other than the member carries the embryo and pregnancy; in gestational surrogacy the embryo may be from a donor or the member.
    Coverage exclusionAll services related to surrogate parents are excluded when the surrogate is not a plan member; surrogate-related services are not covered in that case.
    DistinctionNot to be confused with Reciprocal IVF (which is a covered form of IVF for AFAB members when criteria met).
    Sterilization
    Sterilization — definitionA surgical procedure performed in AFAB or AMAB individuals with the intention of preventing pregnancy.
    Policy relevancePrior sterilization may affect eligibility for infertility services and such cases undergo clinician review per policy exclusions.
    Exclusion noteReversal of voluntary sterilization is listed among services that are not covered unless clinician review determines otherwise.
    Surrogate / Gestational surrogate
    Surrogate / Gestational surrogate — definitionA gestational surrogate is an individual other than the member who carries a pregnancy resulting from an embryo created from donated or member gametes; the embryo does not originate from the surrogate.
    Coverage implicationServices related to surrogates who are not plan members are excluded from coverage under this policy.
    Distinction from reciprocal IVFReciprocal IVF differs and may be covered for AFAB members when eligibility criteria are met.
    Testicular Sperm Aspiration (TESA)
    TESA — definitionTesticular sperm aspiration: needle aspiration of testicular tissue/sperm, performed with local anesthesia and coordinated with egg retrieval; may require open biopsy if insufficient sperm obtained.
    Clinical usePerformed for AMAB members needing sperm retrieval for IVF/ICSI; typically coordinated with egg retrieval and may include cryopreservation.
    Relation to coverageTESA is listed among covered diagnostic/sperm-retrieval services when clinical criteria are met.
    TESE / MicroTESE
    TESE / MicroTESE — definitionTesticular sperm extraction: small incision to examine tubules for sperm; performed with sedation or local anesthesia; MicroTESE is optimal for azoospermia due to production problems and often includes cryopreservation.
    Clinical contextUsed for AMAB members with non-obstructive azoospermia; often coordinated with IVF/ICSI and may include cryopreservation of retrieved sperm.
    Policy noteTESE/MicroTESE coverage is subject to medical necessity criteria and limitations (e.g., not covered when chance of live birth is <5%).
    S4011 — S-code definition
    S4011 — S-code descriptionS4011: In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development (case-rate HCPCS).
    Use in policyS4011 is among the case-rate S-codes requiring prior authorization for IVF cycles under this policy.
    Coding contextListed alongside other S-codes (S4013–S4021) and microtechnique CPTs that require prior authorization for IVF services.
    S4013 — GIFT case rate
    S4013 — definitionS4013: Complete cycle, gamete intrafallopian transfer (GIFT), case rate (HCPCS).
    Policy noteS4013 is listed among IVF case-rate S-codes that require prior authorization.
    Repeated listingS4013 appears multiple times in the policy's coding sections as a case-rate code for IVF cycles.
    S4014 — ZIFT case rate
    S4014 — definitionS4014: Complete cycle, zygote intrafallopian transfer (ZIFT), case rate (HCPCS).
    Policy noteS4014 is designated as a case-rate code for ZIFT and requires prior authorization per the policy coding lists.
    UsageIncluded with other S-codes for complete IVF cycle case rates in the coding section.
    S4015 — complete IVF cycle NOS
    S4015 — definitionS4015: Complete in vitro fertilization cycle, not otherwise specified, case rate (HCPCS).
    Policy noteListed among the IVF case-rate S-codes requiring prior authorization.
    Coding contextAppears with S4011, S4013, S4014 and other S-codes in the IVF coding lists.
    S4016 — frozen IVF cycle
    S4016 — definitionS4016: Frozen in vitro fertilization cycle, case rate (HCPCS).
    Policy noteS4016 is included among S-codes that require prior authorization and denotes a frozen IVF cycle case rate.
    Relation to thaw/transferAssociated with frozen embryo transfer procedures and listed alongside S4018 (frozen transfer cancelled) codes.
    S4017 — incomplete/cancelled case rate
    S4017 — definitionS4017: Incomplete cycle, treatment cancelled prior to stimulation, case rate (HCPCS).
    Policy noteListed among S-codes requiring prior authorization for IVF cycles, representing incomplete/cancelled cycles prior to stimulation.
    Related codesGrouped with S4018, S4020 and S4021 which represent other cancelled/incomplete IVF procedure case rates.
    S4013 (duplicate)
    S4013 (duplicate listing)S4013: Complete cycle, gamete intrafallopian transfer (GIFT), case rate — appears multiple times in coding lists.
    NoteDuplicate listings reflect repeated enumeration of S-codes in the policy's coding sections.
    ActionS4013 requires prior authorization when billed under the infertility benefit.
    S4014 (duplicate)
    S4014 (duplicate listing)S4014: Complete cycle, ZIFT, case rate — repeated in coding sections.
    NoteRepeated appearance in code lists underscores requirement for prior authorization.
    Policy actionPrior authorization required for S4014 as listed.
    S4015 (duplicate)
    S4015 (duplicate)S4015: Complete IVF cycle, NOS, case rate — appears multiple times in coding lists.
    NoteRepeated listing indicates inclusion in the prior-authorization code group.
    Coverage noteS4015 requires prior authorization when billed under the infertility benefit.
    S4016 (duplicate)
    S4016 (duplicate)S4016: Frozen IVF cycle, case rate — repeated in coding sections.
    NoteListed among S-codes requiring prior authorization for IVF cycles.
    Related actionsPrior authorization required for frozen cycle case rates as indicated.
    S4017 (duplicate)
    S4017 (duplicate)S4017: Incomplete cycle cancelled prior to stimulation — duplicate appearance in policy coding lists.
    Policy implicationRepresents an S-code that requires prior authorization when billed; duplicated for emphasis in code sections.
    Related codesGrouped with other cancelled-cycle S-codes (S4018, S4020, S4021).
    S4018 — cancelled frozen transfer
    S4018 — definitionS4018: Frozen embryo transfer procedure cancelled before transfer, case rate (HCPCS).
    Coding contextListed among IVF-related S-codes and requires prior authorization when billed under the IVF benefit.
    NoteDenoted in the coding section as a case-rate code for cancelled frozen transfer procedures.
    S4020 — cancelled before aspiration
    S4020 — definitionS4020: In vitro fertilization procedure cancelled before aspiration, case rate (HCPCS).
    Policy noteIncluded in the list of S-codes requiring prior authorization for IVF cycles and cancelled procedures.
    Effective date noteS4020 and related S-codes referenced with text revision effective 4/1/2025 in coding sections.
    S4021 — cancelled after aspiration
    S4021 — definitionS4021: In vitro fertilization procedure cancelled after aspiration, case rate (HCPCS).
    Coding contextListed with other S-codes (S4013–S4021) requiring prior authorization; appears in the coding section with effective-date notes.
    Policy implicationRepresents a case-rate code for cancelled IVF procedures after aspiration; prior authorization applies when billed.
    Iatrogenic infertility (reference)
    Iatrogenic infertility (duplicate)Infertility resulting from medical treatment (surgery, radiation, chemotherapy, or other treatment including gender-affirming care) — criteria must be met for cryopreservation/storage/thawing codes to be medically necessary.
    Coverage linkCryopreservation, storage and thawing codes are medically necessary only when iatrogenic infertility criteria are satisfied.
    Policy actionFor members who do not meet iatrogenic infertility criteria, listed cryopreservation/storage/thawing codes are not covered.
    Semen analysis CPT codes (89300–89331)
    Semen analysis CPT rangeSemen-analysis and related sperm tests are represented by CPT codes in the 89300–89331 range (examples: 89300 presence/motility; 89310 motility and count; 89320 complete analysis; 89322 Kruger strict morphology).
    Use in diagnostic evaluationThese CPT codes are listed as covered diagnostic evaluation services for infertility and should be used to document the specific semen test performed.
    Associated proceduresComplex sperm prep CPTs (e.g., 89261) and functional tests (89329 hamster penetration) are listed alongside semen analysis codes.
    Chromotubation (58350)
    Chromotubation (58350)Chromotubation of the oviduct: a diagnostic procedure to assess tubal patency using dye; listed among covered diagnostic infertility services.
    Coding noteCPT 58350 appears repeatedly in the Diagnostic Evaluation of Infertility code lists as a covered procedure.
    Clinical roleUsed in tubal diagnostic evaluation as part of infertility workup per policy covered services.
    Tubotubal anastomosis (58750)
    Tubotubal anastomosis (58750)Surgical procedure to reconnect the fallopian tubes; appears in the covered services list for diagnostic/surgical evaluation of infertility.
    Coding appearanceCPT 58750 is included among covered procedures in the diagnostic evaluation section.
    Clinical contextMay be part of surgical treatment/evaluation for tubal factor infertility when indicated.
    Semen analysis — Kruger strict morphology
    Kruger strict morphology (89322)Semen analysis using strict morphologic criteria (Kruger) assessing volume, count, motility and differential morphology; policy cites ≤2% normal forms as an eligibility threshold for AMAB-directed services.
    Role in eligibilityKruger strict morphology results contribute to AMAB eligibility for IVF/ICSI when two analyses meet the policy threshold (≤2% normal forms).
    Diagnostic listingCPT 89322 is listed repeatedly in the diagnostic evaluation code lists as a covered laboratory test.
    58350 — chromotubation CPT
    58350 — CPT entry58350: Chromotubation of oviduct, including materials — listed as a covered diagnostic procedure.
    Use caseUsed to assess tubal patency during diagnostic infertility evaluation.
    Policy codingIncluded in multiple covered-service code lists in the Diagnostic Evaluation section.
    58750 — tubotubal anastomosis CPT
    58750 — CPT entry58750: Tubotubal anastomosis — listed among covered diagnostic and surgical procedure codes for infertility evaluation.
    Clinical roleRepairs fallopian tubes and may be indicated for tubal-factor infertility; appears in covered services lists.
    Coding noteRepeatedly enumerated across diagnostic code lists in the policy.
    Semen evaluation for retrograde ejaculation (urine)
    Semen evaluation for retrograde ejaculation (urine) — CPT 89331Sperm evaluation performed on urine to assess sperm concentration, motility, and morphology for suspected retrograde ejaculation; listed among covered diagnostic services.
    Coding placementCPT 89331 is included in the Diagnostic Evaluation code lists alongside semen analysis CPTs.
    Clinical useUsed when retrograde ejaculation is suspected to document presence of sperm in post-ejaculatory urine sample.

    Background and Policy Scope

    Background: This policy addresses assisted reproductive technologies including artificial insemination (IUI/ICI) and in vitro fertilization (IVF), plus related services such as donor gamete procurement, sperm/egg retrieval, and cryopreservation when indicated. It clarifies eligibility and medical necessity distinctions and notes that coverage details may vary by contract and product type.

    Policy Revision History

    2026-04-01policy_effective_dateLatest

    Policy text revision effective date recorded as 2026-04-01 per document header noting text revision effective date.

    2025-04-01policy_effective_date

    Prior text revision effective date noted in coding section as Text Revised Effective 4/1/2025 for S‑code listings for IVF cycle case rates.